State of the art: cardiac transplantation.
作者： Margot K. Davis , Sharon A. Hunt
DOI: 10.1016/J.TCM.2014.08.004
关键词:
摘要: Recent advances in the management of heart transplant recipients have resulted improved survival, particularly early post-transplant period. Although graft rejection, infection, malignancy, and allograft vasculopathy remain important challenges to long-term recipients, active research these fields continues advance our understanding improve outcomes. This review will provide an overview modern transplantation, summarize current best practices for describe recent field areas research.
elsevier.com
sci-hub.se 参考文章(49)
Jon A. Kobashigawa, Jonathan M. Tobis, Randall C. Starling, E. Murat Tuzcu, Andrew L. Smith, Hannah A. Valantine, Alan C. Yeung, Mandeep R. Mehra, Hitoshi Anzai, Brandy T. Oeser, Kamal H. Abeywickrama, Jane Murphy, Nathalie Cretin, Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. Journal of the American College of Cardiology. ,vol. 45, pp. 1532- 1537 ,(2005) , 10.1016/J.JACC.2005.02.035
Javier Segovia, Gino Gerosa, Luis Almenar, Ugolino Livi, Mario Viganò, Jose Maria Arizón, Nizar Yonan, Thomas G. Di Salvo, Dale G. Renlund, Jon A. Kobashigawa, , Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil at 12 months post-transplantation. Clinical Transplantation. ,vol. 22, pp. 809- 814 ,(2008) , 10.1111/J.1399-0012.2008.00887.X
J. A. Kobashigawa, J. M. Tobis, R. M. Mentzer, H. A. Valantine, R. C. Bourge, M. R. Mehra, F. W. Smart, L. W. Miller, Koji Tanaka, Haiyan Li, D. W. Gjertson, R. D. Gordon, Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial. American Journal of Transplantation. ,vol. 6, pp. 993- 997 ,(2006) , 10.1111/J.1600-6143.2006.01297.X
S. Chih, K. J. Tinckam, H. J. Ross, A survey of current practice for antibody-mediated rejection in heart transplantation. American Journal of Transplantation. ,vol. 13, pp. 1069- 1074 ,(2013) , 10.1111/AJT.12162
H. J. Eisen, J. Kobashigawa, R. C. Starling, D. F. Pauly, A. Kfoury, H. Ross, S.-S. Wang, B. Cantin, A. Van Bakel, G. Ewald, S. Hirt, H. Lehmkuhl, A. Keogh, M. Rinaldi, L. Potena, A. Zuckermann, G. Dong, C. Cornu-Artis, P. Lopez, Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial. American Journal of Transplantation. ,vol. 13, pp. 1203- 1216 ,(2013) , 10.1111/AJT.12181
S. Kuppahally, A. Al-Khaldi, D. Weisshaar, H. A. Valantine, P. Oyer, R. C. Robbins, S. A. Hunt, Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients. American Journal of Transplantation. ,vol. 6, pp. 986- 992 ,(2006) , 10.1111/J.1600-6143.2006.01282.X
David O. Taylor, Mark L. Barr, Branislav Radovancevic, Dale G. Renlund, Robert M. Mentzer Jr, Frank W. Smart, David E. Tolman, O.H. Frazier, James B. Young, Paul VanVeldhuisen, A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus11This study was sponsored by a grant from Fujisawa USA, Deerfield, Illinois.22The authors were working on behalf of the Tacrolimus US Heart Transplant Multicenter Study Group. Other members of the Study Group included (principal investigator listed first): UTAH Cardiac Transplant Program, Salt Lake City, Utah: David O. Taylor, MD, Dale G. Renlund, MD, Abdallah G. Kfoury, MD; St. Luke’s Episcopal Hospital/Texas Heart Institute, Houston, Texas: O. H. Frazier, MD, Branislav Radovancevic, MD, Edward K. Massin, MD; University of Wisconsin Hospitals and Clinics, Madison, Wisconsin: Robert M. Mentzer, Jr., MD, Charles C. Canver, MD, Robert B. Love, MD; Ochsner Medical Foundation, New Orleans, Louisiana: Frank W. Smart, MD, Hector O. Ventura, MD, Dwight D. Stapleton, MD, Mandeep Mehra, MD; University of Southern California, Los Angeles, California: Mark L. Barr, MD, Vaugh A. Starnes, MD; Medical College of Virginia, Richmond, Virginia: David E. Tolman, MD, Albert Guerraty, MD, David Salter, MD; Cleveland Clinic Foundation, Cleveland, Ohio: James B. Young, MD; Data Management and Statistical Coordinating Center-The EMMES Corporation, Potomac, Maryland: Paul VanVeldhuisen, MS, Anne Lindblad, PhD, Anita Yaffe, MSN, MPH. The Journal of Heart and Lung Transplantation. ,vol. 18, pp. 336- 345 ,(1999) , 10.1016/S1053-2498(98)00060-6
Monica Colvin-Adams, Adheesh Agnihotri, Cardiac allograft vasculopathy: current knowledge and future direction Clinical Transplantation. ,vol. 25, pp. 175- 184 ,(2011) , 10.1111/J.1399-0012.2010.01307.X
Eric A. Engels, Ruth M. Pfeiffer, Joseph F. Fraumeni, Bertram L. Kasiske, Ajay K. Israni, Jon J. Snyder, Robert A. Wolfe, Nathan P. Goodrich, A. Rana Bayakly, Christina A. Clarke, Glenn Copeland, Jack L. Finch, Mary Lou Fleissner, Marc T. Goodman, Amy Kahn, Lori Koch, Charles F. Lynch, Margaret M. Madeleine, Karen Pawlish, Chandrika Rao, Melanie A. Williams, David Castenson, Michael Curry, Ruth Parsons, Gregory Fant, Monica Lin, Spectrum of cancer risk among US solid organ transplant recipients. JAMA. ,vol. 306, pp. 1891- 1901 ,(2011) , 10.1001/JAMA.2011.1592
M. Grimm, M. Rinaldi, N. A. Yonan, G. Arpesella, J. M. Arizon Del Prado, L. A. Pulpon, J. P. Villemot, M. Frigerio, J. L. Rodriguez Lambert, M. G. Crespo-Leiro, L. Almenar, D. Duveau, A. Ordonez-Fernandez, J. Gandjbakhch, M. Maccherini, G. Laufer, Superior Prevention of Acute Rejection by Tacrolimus vs. Cyclosporine in Heart Transplant Recipients—A Large European Trial American Journal of Transplantation. ,vol. 6, pp. 1387- 1397 ,(2006) , 10.1111/J.1600-6143.2006.01300.X